Micron Stock Is Up Over 260%. Here's Why It Could Go Even Higher

Micron says AI-driven demand for high-bandwidth memory (HBM) is accelerating as LLMs expand context windows, projecting the HBM TAM to grow from roughly $35 billion last year to about $100 billion by 2028 (~40% CAGR) and warning industry supply will likely remain short beyond calendar 2026. William Blair estimates Micron's earnings could nearly quadruple over the next two years; shares have rallied over 260% in the past 12 months yet still trade at ~12.5x forward EPS with a PEG of 0.7. The combination of structural AI demand, tight HBM supply and attractive valuation suggests meaningful upside for Micron, though consensus 12-month analyst targets are ~12% below the current share price and competition (e.g., Samsung) presents a key downside risk.

Analysis

Market structure: Micron (MU) is a clear near-term winner as HBM demand for LLM context windows pushes TAM from ~$35B (2025) to ~$100B by 2028 (≈40% CAGR). Tight industry supply “beyond 2026” implies multi-year ASP and margin tailwinds for HBM suppliers and semiconductor equipment vendors (ASML/LRCX/AMAT exposure), while buyers of generic DRAM and OEMs facing higher memory bills (clouds, edge device makers) are losers. Pricing power should compress bit-supply elasticity and raise revenue per wafer for incumbents with HBM process competency.

Risk assessment: Tail risks include a Samsung/Taiwan supplier aggressive capacity add (high-impact, medium probability), China demand loss from export controls, or rapid algorithmic memory-efficiency gains reducing HBM need. Near-term (days) volatility will be sentiment-driven; short-term (quarters) depends on Micron’s ASPs and utilization; long-term (2026–2028) hinges on sustained HBM adoption and capital intensity. Hidden dependencies: EUV/tool access, foundry wafer supply and yield curves — all can flip margins quickly.

Trade implications: Favor a size-limited, conviction-weighted long in MU with options overlays: establish an initial 1–3% portfolio long equity position, add 9–18 month call spreads (LEAPS debit spreads) to lever upside while capping premium, and sell near-term covered calls to monetize elevated IV. Relative-value: long MU vs short Samsung Electronics (005930.KS / ADR SSNLF) to express share gain. Monitor HBM ASPs (±10% QoQ), announced capacity adds, and Micron quarterly guidance as entry/scale triggers.

Contrarian angles: Consensus under-weights capex responses — if rivals accelerate HBM fabs, price squeeze could reverse within 12–24 months. The market may also be underpricing cyclicality: similar DRAM booms (2017–2019) ended in sharp oversupply. Unintended consequence: outsized MU run attracts regulatory/geopolitical scrutiny and forces faster global capacity coordination, which could cap multiples.

Key Decisions for Investors

• Establish a 1–3% portfolio long position in Micron (MU) in tranches over the next 6–8 weeks; add to the position on any pullback ≥15% from entry or after two consecutive quarters of HBM ASP growth >10% QoQ. Use a stop-loss at -20% from average entry unless hedged with options.
• Buy 9–18 month MU call debit spreads (e.g., purchase near-the-money LEAPS and sell a higher strike ~25–30% OTM) sized to equal 1–2% portfolio risk to capture upside from HBM-driven EPS expansion while limiting premium exposure.
• Implement a pair trade: long MU (size above) and short Samsung Electronics (005930.KS or ADR SSNLF) sized 0.5–1% portfolio to express expected share gain; unwind if Samsung announces ≥$10B incremental HBM capex or if MU guidance misses by >5% revenue.
• If already long MU, sell 1–3 month covered calls at +10–20% OTM to harvest premium around earnings; alternatively, if unwilling to sell equity, buy 6–9 month 10% OTM puts as insurance (cost <2% portfolio expected) to protect against sentiment-driven drawdowns.
• Rotate 2–4% portfolio weight into semiconductor equipment (ASML, LRCX, AMAT) over 6–12 months to capture secondary benefit of HBM capex; scale out if combined announced industry capacity additions exceed 25% within 12 months or if HBM ASPs decline >15% QoQ.